Cargando…

Optimizing Bariatric Surgery outcomes: the impact of preoperative elevated hemoglobin A1c levels on composite perioperative outcome measures

INTRODUCTION: The use of bariatric surgery in the management of obesity and its related morbidity has significantly increased in the US over the past decade. There is a lack of data on the impact of optimal preoperative glycemic control on the morbidity and mortality following bariatric surgery. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Hart, Alexander, Goffredo, Paolo, Carroll, Rory, Lehmann, Ryan, Nau, Peter, Smith, Jessica, Ahad, Sajida, Bao, Wei, Hassan, Imran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823948/
https://www.ncbi.nlm.nih.gov/pubmed/32789589
http://dx.doi.org/10.1007/s00464-020-07887-9
_version_ 1784646910606311424
author Hart, Alexander
Goffredo, Paolo
Carroll, Rory
Lehmann, Ryan
Nau, Peter
Smith, Jessica
Ahad, Sajida
Bao, Wei
Hassan, Imran
author_facet Hart, Alexander
Goffredo, Paolo
Carroll, Rory
Lehmann, Ryan
Nau, Peter
Smith, Jessica
Ahad, Sajida
Bao, Wei
Hassan, Imran
author_sort Hart, Alexander
collection PubMed
description INTRODUCTION: The use of bariatric surgery in the management of obesity and its related morbidity has significantly increased in the US over the past decade. There is a lack of data on the impact of optimal preoperative glycemic control on the morbidity and mortality following bariatric surgery. The aim of this study was to analyze the impact of hemoglobin (Hb) A1c > 7 on outcomes among patients undergoing Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG). METHODS: Data were extracted from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (2017) and limited to patients undergoing an elective laparoscopic RYGB or SG. Multivariable logistic regression was conducted to adjust for other preoperative variables. RESULTS: A total number of 31,060 (69.3%) patients underwent SG, while 13,754 (30.7%) received RYGB. Patients who were older, male, non-Hispanic, smokers, and those with a higher American Society of Anesthesiologist Classification (ASA) score were more likely to have elevated HbA1c levels. Compared to individuals with normal HbA1c levels, patients with elevated levels had no significant difference in mortality (p = 0.902) but did have a difference in composite morbidity and mortality (p < 0.001). On multivariable analysis, elevated HbA1c, older age, increasing body mass index (BMI), elevated creatinine, longer operations, African American race, receiving RYGB, and having a trainee as surgical assistant were found to increase the odds of having an adverse outcome. No significant difference was found within smoking status, sex, ASA Classification, robotic vs laparoscopic, or if a second attending surgeon was assisting. CONCLUSIONS: HbA1c levels and presence of trainees in the OR are modifiable preoperative risk factors for adverse events following bariatric surgery. Improving preoperative glycemic control may be an effective and achievable quality improvement measure.
format Online
Article
Text
id pubmed-8823948
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-88239482022-02-18 Optimizing Bariatric Surgery outcomes: the impact of preoperative elevated hemoglobin A1c levels on composite perioperative outcome measures Hart, Alexander Goffredo, Paolo Carroll, Rory Lehmann, Ryan Nau, Peter Smith, Jessica Ahad, Sajida Bao, Wei Hassan, Imran Surg Endosc 2020 SAGES Oral INTRODUCTION: The use of bariatric surgery in the management of obesity and its related morbidity has significantly increased in the US over the past decade. There is a lack of data on the impact of optimal preoperative glycemic control on the morbidity and mortality following bariatric surgery. The aim of this study was to analyze the impact of hemoglobin (Hb) A1c > 7 on outcomes among patients undergoing Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG). METHODS: Data were extracted from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (2017) and limited to patients undergoing an elective laparoscopic RYGB or SG. Multivariable logistic regression was conducted to adjust for other preoperative variables. RESULTS: A total number of 31,060 (69.3%) patients underwent SG, while 13,754 (30.7%) received RYGB. Patients who were older, male, non-Hispanic, smokers, and those with a higher American Society of Anesthesiologist Classification (ASA) score were more likely to have elevated HbA1c levels. Compared to individuals with normal HbA1c levels, patients with elevated levels had no significant difference in mortality (p = 0.902) but did have a difference in composite morbidity and mortality (p < 0.001). On multivariable analysis, elevated HbA1c, older age, increasing body mass index (BMI), elevated creatinine, longer operations, African American race, receiving RYGB, and having a trainee as surgical assistant were found to increase the odds of having an adverse outcome. No significant difference was found within smoking status, sex, ASA Classification, robotic vs laparoscopic, or if a second attending surgeon was assisting. CONCLUSIONS: HbA1c levels and presence of trainees in the OR are modifiable preoperative risk factors for adverse events following bariatric surgery. Improving preoperative glycemic control may be an effective and achievable quality improvement measure. Springer US 2020-08-12 2021 /pmc/articles/PMC8823948/ /pubmed/32789589 http://dx.doi.org/10.1007/s00464-020-07887-9 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle 2020 SAGES Oral
Hart, Alexander
Goffredo, Paolo
Carroll, Rory
Lehmann, Ryan
Nau, Peter
Smith, Jessica
Ahad, Sajida
Bao, Wei
Hassan, Imran
Optimizing Bariatric Surgery outcomes: the impact of preoperative elevated hemoglobin A1c levels on composite perioperative outcome measures
title Optimizing Bariatric Surgery outcomes: the impact of preoperative elevated hemoglobin A1c levels on composite perioperative outcome measures
title_full Optimizing Bariatric Surgery outcomes: the impact of preoperative elevated hemoglobin A1c levels on composite perioperative outcome measures
title_fullStr Optimizing Bariatric Surgery outcomes: the impact of preoperative elevated hemoglobin A1c levels on composite perioperative outcome measures
title_full_unstemmed Optimizing Bariatric Surgery outcomes: the impact of preoperative elevated hemoglobin A1c levels on composite perioperative outcome measures
title_short Optimizing Bariatric Surgery outcomes: the impact of preoperative elevated hemoglobin A1c levels on composite perioperative outcome measures
title_sort optimizing bariatric surgery outcomes: the impact of preoperative elevated hemoglobin a1c levels on composite perioperative outcome measures
topic 2020 SAGES Oral
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823948/
https://www.ncbi.nlm.nih.gov/pubmed/32789589
http://dx.doi.org/10.1007/s00464-020-07887-9
work_keys_str_mv AT hartalexander optimizingbariatricsurgeryoutcomestheimpactofpreoperativeelevatedhemoglobina1clevelsoncompositeperioperativeoutcomemeasures
AT goffredopaolo optimizingbariatricsurgeryoutcomestheimpactofpreoperativeelevatedhemoglobina1clevelsoncompositeperioperativeoutcomemeasures
AT carrollrory optimizingbariatricsurgeryoutcomestheimpactofpreoperativeelevatedhemoglobina1clevelsoncompositeperioperativeoutcomemeasures
AT lehmannryan optimizingbariatricsurgeryoutcomestheimpactofpreoperativeelevatedhemoglobina1clevelsoncompositeperioperativeoutcomemeasures
AT naupeter optimizingbariatricsurgeryoutcomestheimpactofpreoperativeelevatedhemoglobina1clevelsoncompositeperioperativeoutcomemeasures
AT smithjessica optimizingbariatricsurgeryoutcomestheimpactofpreoperativeelevatedhemoglobina1clevelsoncompositeperioperativeoutcomemeasures
AT ahadsajida optimizingbariatricsurgeryoutcomestheimpactofpreoperativeelevatedhemoglobina1clevelsoncompositeperioperativeoutcomemeasures
AT baowei optimizingbariatricsurgeryoutcomestheimpactofpreoperativeelevatedhemoglobina1clevelsoncompositeperioperativeoutcomemeasures
AT hassanimran optimizingbariatricsurgeryoutcomestheimpactofpreoperativeelevatedhemoglobina1clevelsoncompositeperioperativeoutcomemeasures